The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury
Open accessAbstract
Background & Aims: Hepatic ischemia-reperfusion injury (IRI) is a major complication of hemorrhagic shock, liver resection and transplantation. YAP, the effector of Hippo pathway, is essential in determining cell fate and maintaining homeostasis in the liver. Methods: This study systemically evaluated putative role of YAP/Hippo signaling in human orthotopic liver transplantation (OLT) and in a murine model of liver warm IRI. Results: Hepatic biopsy specimens from OLT patients (n=60) were collected after 2-10h of cold storage (pre-OLT) and 3h post-reperfusion (post-OLT) under an institutional research broad protocol, and screened by Western blots. High post-OLT YAP expression was correlated with well-preserved histology and improved hepatocellular function at post-operative day 1-7 (POD 1-7). In mice, the ischemia insult (90min) triggered intrinsic hepatic YAP expression, peaking at 1-6h of reperfusion. Activating YAP protected liver against IR-stress, promoted downstream regenerative/anti-oxidative gene induction, diminished oxidative stress and necrosis/apoptosis, and suppressed innate inflammation response. In contrast, inhibiting YAP aggravated hepatic IRI and suppressed repair/anti-oxidative genes. In parallel in vitro studies, activating YAP prevented hypoxia-reoxygenation induced stress in mouse hepatocyte cultures. Although sALT levels were progressively decreased from 6h to 7d post-reperfusion in IR-stressed mouse livers, hepatic fibrogenesis was steadily developing. Interestingly, YAP activation suppressed extracellular matrix synthesis and diminished hepatic stellate cells (HSCs) activation, whereas YAP inhibition significantly delayed hepatic repair, potentiated HSCs activation, and enhanced liver fibrosis at 7d post-IRI. However, YAP activation failed to protect Nrf2-deficient livers against IR-mediated damage, leading to extensive fibrosis. Conclusion: Our novel findings document the crucial role of YAP in IR-mediated hepatocellular damage and liver fibrogenesis, and imply the therapeutic potential for the management of sterile liver inflammation in transplant recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443
Macrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
Hippo Pathway Activity Influences Liver Cell Fate
Yimlamai, D., Christodoulou, C., Galli, G. G., Yanger, K., Pepe-Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B. Z., & Camargo, F. D. (2014) · Cell · doi:10.1016/j.cell.2014.03.060 · Cited by 857
Cited by
The Hippo signalling pathway and its implications in human health and diseases
Fu, M., Hu, Y., Lan, T., Guan, K.-L., Luo, T., & Luo, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01191-9 · Cited by 742
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Danger signals in liver injury and restoration of homeostasis
Han, H., Desert, R., Das, S., Song, Z., Athavale, D., Ge, X., & Nieto, N. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.033 · Cited by 127
ROS/RNS as molecular signatures of chronic liver diseases
Che, Z., Zhou, Z., Li, S.-Q., Gao, L., Xiao, J., & Wong, N.-K. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.001 · Cited by 110
Si, Z., Zhao, S., Zhang, Z., Chen, T., Wang, R., Dong, C., Wang, K., Sun, C., Song, Z., Shen, Z., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04353-y · Cited by 10
Metadata
- Authors
- Liu, Y., Lu, T., Zhang, C., Xu, J., Xue, Z., Busuttil, R. W., Xu, N., Xia, Q., Kupiec-Weglinski, J. W., & Ji, H.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 71
- Issue
- 4
- Pages
- 719-730
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2950360205
- Cited by
- 278
- References
- 39
- FWCI
- 22.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. https://app.cochat.ai/papers/10.1016/j.jhep.2019.05.029
- The paper
- Liu, Y., Lu, T., Zhang, C., Xu, J., Xue, Z., Busuttil, R. W., Xu, N., Xia, Q., Kupiec-Weglinski, J. W., & Ji, H. (2019). Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2019.05.029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.